TES of Artemether-lumefantrine for Pf in the Philippines in 2017-2018

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

December 28, 2018

Study Completion Date

December 28, 2018

Conditions
Malaria,FalciparumMalaria Recrudescence
Interventions
DRUG

Artemether-lumefantrine

"Artemether-lumefantrine will be administered for 3 days according to body weight (Days 0 and 8 hours after, 1 and 2). Dosage depending on body weight or age if weight cannot be determined.~Dosage: 1 tablet contains 20 mg artemether and 120 mg lumefantrine Dosage per weight: 1 tablet (5 to \<16kg); 2 tablets (15 to \<25kg); 3 tablets (25 to \<35kg), 4 tablets for \>35 kg) Dosage per age, if weight cannot be determined: 1 tablet (6 months old to 3 years old); 2 tablets (4 to 8 years old); 3 tablets (9-13 years old), 4 tablets (\>13 years old)"

DRUG

Primaquine

For Pf patients, primaquine at 0.75 mg base/kg body weight single dose will be given on Day 3 for Pf patients; For Pv patients primaquine will be withheld for 28 days and will be given after Day 28 follow-up, at 0.25 mg base/kg per day for 14 days.

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

Research Institute for Tropical Medicine, Philippines

OTHER_GOV

NCT05958810 - TES of Artemether-lumefantrine for Pf in the Philippines in 2017-2018 | Biotech Hunter | Biotech Hunter